- Home
- SCYX vs XCUR Comparison
SCYX vs XCUR Comparison
Compare SCYX & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- XCUR
- Stock Information
- Founded
- SCYX 1999
- XCUR 2011
- Country
- SCYX United States
- XCUR United States
- Employees
- SCYX N/A
- XCUR N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- SCYX Health Care
- XCUR Health Care
- Exchange
- SCYX Nasdaq
- XCUR Nasdaq
- Market Cap
- SCYX 40.9M
- XCUR N/A
- IPO Year
- SCYX 2014
- XCUR N/A
- Fundamental
- Price
- SCYX $1.03
- XCUR $13.94
- Analyst Decision
- SCYX Buy
- XCUR
- Analyst Count
- SCYX 1
- XCUR 0
- Target Price
- SCYX N/A
- XCUR N/A
- AVG Volume (30 Days)
- SCYX 135.5K
- XCUR 53.4K
- Earning Date
- SCYX 03-12-2025
- XCUR 03-18-2025
- Dividend Yield
- SCYX N/A
- XCUR N/A
- EPS Growth
- SCYX N/A
- XCUR N/A
- EPS
- SCYX N/A
- XCUR N/A
- Revenue
- SCYX $3,746,000.00
- XCUR $500,000.00
- Revenue This Year
- SCYX $1,541.00
- XCUR N/A
- Revenue Next Year
- SCYX $111.43
- XCUR N/A
- P/E Ratio
- SCYX N/A
- XCUR N/A
- Revenue Growth
- SCYX N/A
- XCUR N/A
- 52 Week Low
- SCYX $0.82
- XCUR $1.44
- 52 Week High
- SCYX $3.07
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- SCYX 50.55
- XCUR 58.67
- Support Level
- SCYX $1.00
- XCUR $12.07
- Resistance Level
- SCYX $1.06
- XCUR $15.91
- Average True Range (ATR)
- SCYX 0.07
- XCUR 1.92
- MACD
- SCYX 0.02
- XCUR 0.31
- Stochastic Oscillator
- SCYX 63.30
- XCUR 62.32
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.